Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carpentier, A.
Right arrow Articles by Lewis, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carpentier, A.
Right arrow Articles by Lewis, G. F.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:1867-1875, 2002
© 2002 by the American Diabetes Association, Inc.

Sensitivity to Acute Insulin-Mediated Suppression of Plasma Free Fatty Acids Is Not a Determinant of Fasting VLDL Triglyceride Secretion in Healthy Humans

André Carpentier1, Bruce W. Patterson2, Nathalie Leung1, and Gary F. Lewis1

1 Department of Medicine, Division of Endocrinology, University of Toronto, and the Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada
2 Department of Internal Medicine and Center for Human Nutrition, Washington University School of Medicine, St. Louis, Missouri

One important mechanism whereby obesity-associated insulin resistance leads to VLDL overproduction is thought to be by the increased flux of free fatty acids (FFAs) from extrahepatic tissues to liver, which arises as a direct consequence of impaired insulin action in adipose tissue and skeletal muscle. The aim of the present study was to address whether direct measures of peripheral tissue insulin sensitivity with regard to FFAs and glucose in the fasting state are good predictors of postabsorptive VLDL triglyceride secretion rate (VLDL-TG ASR) in humans, independent of obesity. Eighteen healthy control subjects, after an overnight fast, underwent three studies 3 weeks apart, in random order. Study 1: VLDL-TG levels, fractional clearance rate (per h), and VLDL-TG ASR were determined after an intravenous bolus of [1,1,2,3,3-2H5] glycerol. Study 2: Insulin sensitivity (SI), acute insulin response (AIR), and acute C-peptide response to glucose were assessed by frequently sampled intravenous glucose tolerance test using the minimal model approach. Study 3: Insulin-mediated suppression of plasma FFAs (k) and insulin clearance were assessed in response to a low-dose stepwise intravenous insulin infusion. BMI (R2 = 0.54), AIR, and fasting insulin levels were positively and SI negatively correlated with VLDL-TG ASR, but there was no significant association with plasma FFAs or k. Only BMI remained significantly associated with VLDL-TG ASR in multivariate analysis. The best multivariate model for VLDL-TG ASR (R2 = 0.61, P = 0.0008) included BMI (P = 0.0008) and SI (P = 0.12, inversely correlated). VLDL-TG secretion is predicted by BMI, independently of direct measures of insulin sensitivity. The sensitivity to insulin’s acute suppressive effect on plasma FFA levels during fasting is not an important determinant of postabsorptive VLDL-TG secretion in humans.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Magkos, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer
A single 1-h bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics in untrained lean men
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1568 - E1574.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Magkos, B. W. Patterson, B. S. Mohammed, S. Klein, and B. Mittendorfer
Women Produce Fewer but Triglyceride-Richer Very Low-Density Lipoproteins than Men
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1311 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. A. M. den Boer, P. J. Voshol, F. Kuipers, J. A. Romijn, and L. M. Havekes
Hepatic glucose production is more sensitive to insulin-mediated inhibition than hepatic VLDL-triglyceride production
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1360 - E1364.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. C. Gormsen, M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen
Energy expenditure, insulin, and VLDL-triglyceride production in humans
J. Lipid Res., October 1, 2006; 47(10): 2325 - 2332.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Magkos, D. C. Wright, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer
Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men
Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E355 - E362.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
A. Nilsson and R.-D. Duan
Absorption and lipoprotein transport of sphingomyelin
J. Lipid Res., January 1, 2006; 47(1): 154 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Adiels, J. Boren, M. J. Caslake, P. Stewart, A. Soro, J. Westerbacka, B. Wennberg, S.-O. Olofsson, C. Packard, and M.-R. Taskinen
Overproduction of VLDL1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia
Arterioscler. Thromb. Vasc. Biol., August 1, 2005; 25(8): 1697 - 1703.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
M. Adiels, C. Packard, M. J. Caslake, P. Stewart, A. Soro, J. Westerbacka, B. Wennberg, S.-O. Olofsson, M.-R. Taskinen, and J. Boren
A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions
J. Lipid Res., January 1, 2005; 46(1): 58 - 67.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. S. Cohn, B. W. Patterson, K. D. Uffelman, J. Davignon, and G. Steiner
Rate of Production of Plasma and Very-Low-Density Lipoprotein (VLDL) Apolipoprotein C-III Is Strongly Related to the Concentration and Level of Production of VLDL Triglyceride in Male Subjects with Different Body Weights and Levels of Insulin Sensitivity
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3949 - 3955.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Alam, M. Stolinski, C. Pentecost, M. A. Boroujerdi, R. H. Jones, P. H. Sonksen, and A. M. Umpleby
The Effect of a Six-Month Exercise Program on Very Low-Density Lipoprotein Apolipoprotein B Secretion in Type 2 Diabetes
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 688 - 694.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Pettersson-Fernholm, M. K. Karvonen, J. Kallio, C. M. Forsblom, M. Koulu, U. Pesonen, J. A. Fagerudd, and P.-H. Groop
Leucine 7 to Proline 7 Polymorphism in the Preproneuropeptide Y Is Associated With Proteinuria, Coronary Heart Disease, and Glycemic Control in Type 1 Diabetic Patients
Diabetes Care, February 1, 2004; 27(2): 503 - 509.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.